![April Dovholuk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
April Dovholuk formerly worked at Replimune Group, Inc., as Senior VP-Clinical Development Operations and Centessa Pharmaceuticals Plc, as Senior Vice President-Operations Development from 2023 to 2024.
Dr. Dovholuk received her undergraduate degree from Cornell University.
Eerdere bekende functies van April Dovholuk
| Bedrijven | Functie | Einde |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Operationeel Directeur | 01-11-2024 |
| REPLIMUNE GROUP, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van April Dovholuk
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
